Marengo Therapeutics Funding: $80M Raised, Series B (2021)
Marengo Therapeutics is based in Cambridge, MA. It has raised $80M in total funding. Latest round: Series B.
Marengo Therapeutics funding overview
Marengo Therapeutics is based in Cambridge, MA. Marengo Therapeutics has raised $80M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in November 2021. The round record for Marengo Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Michael Ehlers, ATP (apple Tree Partners). 2 distinct backers are named across the disclosed rounds.
Marengo Therapeutics at a glance
Total raised
$80M
Latest round
Series B
Latest round date
November 2021
Headquarters
Cambridge, MA
Notable investors
Michael Ehlers, ATP (apple Tree Partners)
Frequently asked about Marengo Therapeutics funding
How much has Marengo Therapeutics raised?
Marengo Therapeutics has raised $80M in total disclosed funding across the rounds on record.
Who has invested in Marengo Therapeutics?
Michael Ehlers, ATP (apple Tree Partners) are named among the investors backing Marengo Therapeutics.
What was the latest Marengo Therapeutics funding round?
The most recent disclosed round is a Series B, announced in November 2021.
Where is Marengo Therapeutics based?
Marengo Therapeutics is based in Cambridge, MA.
When did Marengo Therapeutics last raise?
The last disclosed Marengo Therapeutics round closed in November 2021 at Series B.
Marengo Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Cambridge below to benchmark round size and investor mix.
